search
Back to results

Wallis Mechanical Normalization System for Low Back Pain

Primary Purpose

Low Back Pain

Status
Unknown status
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Interspinous process and dynamic stabilization
Conservative Care
Sponsored by
Zimmer Spine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain focused on measuring Degenerative Disc Disease of the lumbar spine

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Subjects must meet all inclusion and exclusion criteria listed below for participation in the study. Inclusion Criteria: Ages 18-60; male/female. Diagnosis of mild to moderate degenerative disc disease (DDD), which requires: back pain of at least 30/100 as measured on a visual analog scale, with or without leg (radicular) pain; and radiographic confirmation of the following, as determined by computed tomography (CT), magnetic resonance imaging (MRI), discography, plain film, myelography and/or flexion/extension films: up to Modic I changes on MRI, with decreased disc height up to 50% of adjacent level, and no significant osteophytes; with or without a contained disc herniation. Candidate for either surgery with Wallis or aggressive conservative management. Requires treatment at one or two lumbar levels between L1 and L5. Experienced symptoms for at least three months without significant resolution. Has undergone a regimen of at least four weeks of anti-inflammatory medication for the current episode of back pain and had exposure to physical therapy. Minimum baseline Oswestry score of 30% (15/50). Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol. Voluntarily signs the subject informed consent. Exclusion Criteria: Significant neuroforaminal compression requiring discectomy or foraminotomy Radiographic evidence of DDD at L5-S1 Radiographic confirmation of severe facet joint disease or degeneration. History of any lumbar disc treatment intended to remove the disc, e.g. surgery, intradiscal electrothermal therapy (IDET), laser or enzymes such as chymopapain. Clinically compromised vertebral bodies at the affected level due to current or past trauma, e.g., sustained pathological fracture or multiple fractures of vertebrae. Unwilling to comply with 8 weeks of physical therapy. Subject refuses to consider epidural or facet injections for leg or back pain. Active systemic infection or infection at the operative site Osteoporosis. The Simple Calculated Osteoporosis Risk Estimation (SCORE) questionnaire will be used to screen subjects for osteoporosis; subjects whose screening suggests risk will undergo a dual-energy x-ray absorptiometry (DEXA) scan. Subjects will be excluded if the DEXA scan results indicate a T-score equal to or worse than -2.5, in accordance with the World Health Organization definition of osteoporosis. Paget's disease, osteomalacia, or any other metabolic bone disease other than osteoporosis, which is addressed above Rheumatoid arthritis, lupus, or other autoimmune disease AIDS, HIV, or Hepatitis Known allergy to titanium, polyetheretherketone, or polyester Current pathological lesions, such as tumor Congenital lumbar spinal stenosis Clinically relevant instability on flexion-extension as determined by the investigator by overlaying films. Cauda equina syndrome Pregnant at time of enrollment or with plans to become pregnant within the next three years Concomitant conditions requiring steroid treatment or prior steroid usage for more than one of the preceding three months Diabetes mellitus requiring daily insulin management Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines (body mass index [BMI] > 35) Fusion previously performed at the same or an adjacent level; or other instrumented spinal surgery at the operative level. Prior participation in study of any experimental spinal implant or treatment Pending litigation against a health care professional Life expectancy of less than three years History of any invasive malignancy (except for non-melanoma skin cancer), unless treated with curative intent and with no clinical signs or symptoms of the malignancy for at least 5 years Current or recent history of substance abuse (alcoholism and/or narcotic addiction) requiring intervention Spondylolysis Translation greater than 2 mm at the symptomatic level Significant scoliosis (Cobb angle > 25 degrees) or scoliosis otherwise requiring surgical correction Kyphosis requiring surgical correction

Sites / Locations

  • Spine Specialists of Arizona
  • Arizona Institute for Minimally Invasive Spine Care
  • Spine Source
  • UCLA Spine Center
  • Boulder Neurosurgical Associates
  • The Spine Education & Research Institute
  • Emory University Medical Center
  • Illinois Bone & Joint Institute
  • Fort Wayne Orthopedics
  • Greater Baltimore Medical Center
  • Orthopaedic Associates
  • The Orthopedic Center of St. Louis
  • Orthopedic Spine Care of Long Island
  • Orthopedic Spine Associates
  • The Orthopedic Specialty Center (Abington Hospital)
  • Central Texas Spine Institute
  • TBI/ Plano Presbyterian Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

1

2

Arm Description

Interspinous process and dynamic stabilization

Conservative Care

Outcomes

Primary Outcome Measures

To provide a safety cohort for the Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine

Secondary Outcome Measures

Full Information

First Posted
August 23, 2005
Last Updated
October 3, 2011
Sponsor
Zimmer Spine
Collaborators
Zimmer Biomet
search

1. Study Identification

Unique Protocol Identification Number
NCT00134537
Brief Title
Wallis Mechanical Normalization System for Low Back Pain
Study Type
Interventional

2. Study Status

Record Verification Date
October 2011
Overall Recruitment Status
Unknown status
Study Start Date
November 2004 (undefined)
Primary Completion Date
April 2011 (Actual)
Study Completion Date
April 2012 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zimmer Spine
Collaborators
Zimmer Biomet

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to compare improvement in low back pain with Wallis (interspinous process implant) to exercise and injections.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain
Keywords
Degenerative Disc Disease of the lumbar spine

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Interspinous process and dynamic stabilization
Arm Title
2
Arm Type
Active Comparator
Arm Description
Conservative Care
Intervention Type
Device
Intervention Name(s)
Interspinous process and dynamic stabilization
Intervention Description
Interspinous process and dynamic stabilization
Intervention Type
Device
Intervention Name(s)
Conservative Care
Intervention Description
Medication, exercise and spinal injections
Primary Outcome Measure Information:
Title
To provide a safety cohort for the Prospective, Multi-center, Randomized, Active-Controlled Study of the Wallis System for the Treatment of Mild to Moderate Degenerative Disc Disease of the Lumbar Spine
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Subjects must meet all inclusion and exclusion criteria listed below for participation in the study. Inclusion Criteria: Ages 18-60; male/female. Diagnosis of mild to moderate degenerative disc disease (DDD), which requires: back pain of at least 30/100 as measured on a visual analog scale, with or without leg (radicular) pain; and radiographic confirmation of the following, as determined by computed tomography (CT), magnetic resonance imaging (MRI), discography, plain film, myelography and/or flexion/extension films: up to Modic I changes on MRI, with decreased disc height up to 50% of adjacent level, and no significant osteophytes; with or without a contained disc herniation. Candidate for either surgery with Wallis or aggressive conservative management. Requires treatment at one or two lumbar levels between L1 and L5. Experienced symptoms for at least three months without significant resolution. Has undergone a regimen of at least four weeks of anti-inflammatory medication for the current episode of back pain and had exposure to physical therapy. Minimum baseline Oswestry score of 30% (15/50). Physically and mentally able to comply with the protocol, including ability to read and complete required forms, and willing and able to adhere to the follow-up requirements of the protocol. Voluntarily signs the subject informed consent. Exclusion Criteria: Significant neuroforaminal compression requiring discectomy or foraminotomy Radiographic evidence of DDD at L5-S1 Radiographic confirmation of severe facet joint disease or degeneration. History of any lumbar disc treatment intended to remove the disc, e.g. surgery, intradiscal electrothermal therapy (IDET), laser or enzymes such as chymopapain. Clinically compromised vertebral bodies at the affected level due to current or past trauma, e.g., sustained pathological fracture or multiple fractures of vertebrae. Unwilling to comply with 8 weeks of physical therapy. Subject refuses to consider epidural or facet injections for leg or back pain. Active systemic infection or infection at the operative site Osteoporosis. The Simple Calculated Osteoporosis Risk Estimation (SCORE) questionnaire will be used to screen subjects for osteoporosis; subjects whose screening suggests risk will undergo a dual-energy x-ray absorptiometry (DEXA) scan. Subjects will be excluded if the DEXA scan results indicate a T-score equal to or worse than -2.5, in accordance with the World Health Organization definition of osteoporosis. Paget's disease, osteomalacia, or any other metabolic bone disease other than osteoporosis, which is addressed above Rheumatoid arthritis, lupus, or other autoimmune disease AIDS, HIV, or Hepatitis Known allergy to titanium, polyetheretherketone, or polyester Current pathological lesions, such as tumor Congenital lumbar spinal stenosis Clinically relevant instability on flexion-extension as determined by the investigator by overlaying films. Cauda equina syndrome Pregnant at time of enrollment or with plans to become pregnant within the next three years Concomitant conditions requiring steroid treatment or prior steroid usage for more than one of the preceding three months Diabetes mellitus requiring daily insulin management Extreme obesity, as defined by National Institutes of Health (NIH) Clinical Guidelines (body mass index [BMI] > 35) Fusion previously performed at the same or an adjacent level; or other instrumented spinal surgery at the operative level. Prior participation in study of any experimental spinal implant or treatment Pending litigation against a health care professional Life expectancy of less than three years History of any invasive malignancy (except for non-melanoma skin cancer), unless treated with curative intent and with no clinical signs or symptoms of the malignancy for at least 5 years Current or recent history of substance abuse (alcoholism and/or narcotic addiction) requiring intervention Spondylolysis Translation greater than 2 mm at the symptomatic level Significant scoliosis (Cobb angle > 25 degrees) or scoliosis otherwise requiring surgical correction Kyphosis requiring surgical correction
Facility Information:
Facility Name
Spine Specialists of Arizona
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85015
Country
United States
Facility Name
Arizona Institute for Minimally Invasive Spine Care
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85020
Country
United States
Facility Name
Spine Source
City
Beverly Hills
State/Province
California
ZIP/Postal Code
90212
Country
United States
Facility Name
UCLA Spine Center
City
Santa Monica
State/Province
California
ZIP/Postal Code
90404
Country
United States
Facility Name
Boulder Neurosurgical Associates
City
Boulder
State/Province
Colorado
ZIP/Postal Code
80304
Country
United States
Facility Name
The Spine Education & Research Institute
City
Thornton
State/Province
Colorado
ZIP/Postal Code
80229
Country
United States
Facility Name
Emory University Medical Center
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30329
Country
United States
Facility Name
Illinois Bone & Joint Institute
City
Morton Grove
State/Province
Illinois
ZIP/Postal Code
60053
Country
United States
Facility Name
Fort Wayne Orthopedics
City
Fort Wayne
State/Province
Indiana
ZIP/Postal Code
46804
Country
United States
Facility Name
Greater Baltimore Medical Center
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21204
Country
United States
Facility Name
Orthopaedic Associates
City
Towson
State/Province
Maryland
ZIP/Postal Code
21204
Country
United States
Facility Name
The Orthopedic Center of St. Louis
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Facility Name
Orthopedic Spine Care of Long Island
City
Melville
State/Province
New York
ZIP/Postal Code
11747
Country
United States
Facility Name
Orthopedic Spine Associates
City
Eugene
State/Province
Oregon
ZIP/Postal Code
97401
Country
United States
Facility Name
The Orthopedic Specialty Center (Abington Hospital)
City
Willow Grove
State/Province
Pennsylvania
ZIP/Postal Code
19090
Country
United States
Facility Name
Central Texas Spine Institute
City
Austin
State/Province
Texas
ZIP/Postal Code
78731
Country
United States
Facility Name
TBI/ Plano Presbyterian Hospital
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Wallis Mechanical Normalization System for Low Back Pain

We'll reach out to this number within 24 hrs